This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Lysogene Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of LYS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders391,9362.21%
Public Companies950,6065.37%
Institutions2,000,04411.3%
VC/PE Firms3,552,27720.1%
General Public10,801,46861%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.9%.


Top Shareholders

Top 7 shareholders own 38.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.1%
Sofinnova Partners SAS
3,552,277€992.9k0%0.56%
5.37%
Sarepta Therapeutics, Inc.
950,606€265.7k0%no data
4.72%
Invus Public Equities Advisors, LLC
835,975€233.7k0%8.96%
4%
OrbiMed Advisors LLC
708,048€197.9k0%no data
2.29%
Tocqueville Finance SA
406,021€113.5k0%no data
2.21%
Karen Pignet-Aiach
391,936€109.5k0%no data
0.28%
Gestys SA
50,000€14.0k0%0.38%